Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

The stiffness of a wound affects hair growth during healing, with less stiff areas growing more hair.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Curcuma aeruginosa Roxb. may help treat hair loss by affecting specific biological pathways.

Injecting lab-grown hair cells into the scalp can regrow hair.

The developed system could effectively treat hair loss and promote hair growth.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Gray hair can potentially be reversed, leading to new treatments.

The African spiny mouse heals skin without scarring due to different protein activity compared to the common house mouse, which heals with scarring.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Minoxidil needs activation to work, and minoxidil sulfate helps with hair growth and blood pressure.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

The paper concludes that understanding melanocyte development can help in insights into skin diseases and melanoma diversity.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

Platelet-based therapies using a patient's own blood show promise for skin and hair regeneration but require more research for confirmation.

Melanocytes are diverse cells important for pigmentation and skin health, influenced by genetics and environment.

A group has developed therapies that show promise for treating cancer and various other conditions.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

PRP is a promising treatment for autoimmune hair loss but its exact workings are not fully understood.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.